Alfasigma S.p.A. Tender Offer for Intercept Pharmaceuticals, Inc. Commences

Contributed by: Business Wire

Logo

Tags

Health

Pharmaceutical

Intercept Pharmaceuticals, Inc.

More Like This

Alfasigma completes acquisition of Intercept Pharmaceuticals, Inc.

Alfasigma S.p.A. Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Pending Acquisition of Intercept Pharmaceuticals, Inc.

CONSTANTIA FLEXIBLES TO ACQUIRE A MAJORITY OF SHARES OF ALUFLEXPACK AG AND ANNOUNCES PUBLIC TENDER OFFER FOR REMAINING SHARES

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

infas Holding Aktiengesellschaft: Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014

TECPETROL ANNOUNCES SUCCESSFUL TAKE-OVER BID TO ACQUIRE CONTROL OF ALPHA LITHIUM CORPORATION AND MANDATORY EXTENSION OF OFFER TO OCTOBER 31, 2023

TECPETROL REMINDS SHAREHOLDERS OF ALPHA LITHIUM CORPORATION TO TENDER THEIR SHARES BEFORE OCTOBER 20TH DEADLINE